A theoretical study on the carbocationic reactivity of 2-fluoroallylic alcohols and derivatives explains some experimental findings. An outline is also given of synthetic approaches towards fluoroallylic amines and more complex carbon skeletons starting with fluoroallylic alcohols.
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
申请人:Wang Yanjun Eric
公开号:US20070293548A1
公开(公告)日:2007-12-20
Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.
INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES
申请人:WANG Eric Yanjun
公开号:US20110269811A1
公开(公告)日:2011-11-03
Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-1). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.
[EN] INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES<br/>[FR] INHIBITEURS D'ADHÉRENCE MÉDIÉE PAR L'AMINE OXYDASE SENSIBLE AUX SEMI-CARBAZIDES (SSAO) ET LA VAP-1 UTILISÉS DANS LE TRAITEMENT ET LA PRÉVENTION DE MALADIES
申请人:JOLLA PHARMA
公开号:WO2007120528A2
公开(公告)日:2007-10-25
[EN] Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-I). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke. [FR] L'invention concerne des compositions et des méthodes d'utilisation des compositions dans le traitement de maladies inflammatoires et de troubles immuns. L'invention concerne également des composés allylamino qui constituent des inhibiteurs de l'amine oxydase sensible aux semi-carbazides (SSAO) et/ou de la protéine 1 d'adhérence vasculaire (VAP-I). Lesdits composés sont utilisés d'un point de vue thérapeutique dans la suppression de l'inflammation et des réponses inflammatoires, et dans le traitement de divers troubles, y compris la sclérose en plaques et l'accident vasculaire cérébral.
Stereoselective synthesis of β-fluoroallyl alcohols
A theoretical study on the carbocationic reactivity of 2-fluoroallylic alcohols and derivatives explains some experimental findings. An outline is also given of synthetic approaches towards fluoroallylic amines and more complex carbon skeletons starting with fluoroallylic alcohols.